BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

204 related articles for article (PubMed ID: 28184946)

  • 1. Uptake of 111In-labeled fully human monoclonal antibody TSP-A18 reflects transferrin receptor expression in normal organs and tissues of mice.
    Sugyo A; Tsuji AB; Sudo H; Nomura F; Satoh H; Koizumi M; Kurosawa G; Kurosawa Y; Saga T
    Oncol Rep; 2017 Mar; 37(3):1529-1536. PubMed ID: 28184946
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Preclinical evaluation of ⁸⁹Zr-labeled human antitransferrin receptor monoclonal antibody as a PET probe using a pancreatic cancer mouse model.
    Sugyo A; Tsuji AB; Sudo H; Nagatsu K; Koizumi M; Ukai Y; Kurosawa G; Zhang MR; Kurosawa Y; Saga T
    Nucl Med Commun; 2015 Mar; 36(3):286-94. PubMed ID: 25460304
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Evaluation of Efficacy of Radioimmunotherapy with 90Y-Labeled Fully Human Anti-Transferrin Receptor Monoclonal Antibody in Pancreatic Cancer Mouse Models.
    Sugyo A; Tsuji AB; Sudo H; Okada M; Koizumi M; Satoh H; Kurosawa G; Kurosawa Y; Saga T
    PLoS One; 2015; 10(4):e0123761. PubMed ID: 25893775
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The in vitro antitumor effect and in vivo tumor-specificity distribution of human-mouse chimeric antibody against transferrin receptor.
    Qing Y; Shuo W; Zhihua W; Huifen Z; Ping L; Lijiang L; Xiaorong Z; Liming C; Daiwen X; Yu H; Wei X; Min F; Zuohua F; Guanxin S
    Cancer Immunol Immunother; 2006 Sep; 55(9):1111-21. PubMed ID: 16341531
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Inhibition of gallium-67 uptake in melanoma by an anti-human transferrin receptor monoclonal antibody.
    Chan SM; Hoffer PB; Maric N; Duray P
    J Nucl Med; 1987 Aug; 28(8):1303-7. PubMed ID: 3475407
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Structural, functional, and tissue distribution analysis of human transferrin receptor-2 by murine monoclonal antibodies and a polyclonal antiserum.
    Deaglio S; Capobianco A; Calì A; Bellora F; Alberti F; Righi L; Sapino A; Camaschella C; Malavasi F
    Blood; 2002 Nov; 100(10):3782-9. PubMed ID: 12393650
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Immunohistochemical localization of the murine transferrin receptor (TfR) on blood-tissue barriers using a novel anti-TfR monoclonal antibody.
    Kissel K; Hamm S; Schulz M; Vecchi A; Garlanda C; Engelhardt B
    Histochem Cell Biol; 1998 Jul; 110(1):63-72. PubMed ID: 9681691
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Development of human single-chain antibodies to the transferrin receptor that effectively antagonize the growth of leukemias and lymphomas.
    Crépin R; Goenaga AL; Jullienne B; Bougherara H; Legay C; Benihoud K; Marks JD; Poul MA
    Cancer Res; 2010 Jul; 70(13):5497-506. PubMed ID: 20530676
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Therapeutic bispecific antibodies cross the blood-brain barrier in nonhuman primates.
    Yu YJ; Atwal JK; Zhang Y; Tong RK; Wildsmith KR; Tan C; Bien-Ly N; Hersom M; Maloney JA; Meilandt WJ; Bumbaca D; Gadkar K; Hoyte K; Luk W; Lu Y; Ernst JA; Scearce-Levie K; Couch JA; Dennis MS; Watts RJ
    Sci Transl Med; 2014 Nov; 6(261):261ra154. PubMed ID: 25378646
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Heterogeneity of the human transferrin receptor and use of anti-transferrin receptor antibodies to detect tumours in vivo.
    Panaccio M; Zalcberg JR; Thompson CH; Leyden MJ; Sullivan JR; Lichtenstein M; McKenzie IF
    Immunol Cell Biol; 1987 Dec; 65 ( Pt 6)():461-72. PubMed ID: 2452131
    [TBL] [Abstract][Full Text] [Related]  

  • 11. In vivo biodistribution of a humanized anti-Lewis Y monoclonal antibody (hu3S193) in MCF-7 xenografted BALB/c nude mice.
    Clarke K; Lee FT; Brechbiel MW; Smyth FE; Old LJ; Scott AM
    Cancer Res; 2000 Sep; 60(17):4804-11. PubMed ID: 10987290
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Delivery of radionuclides to pretargeted monoclonal antibodies using dihydrofolate reductase and methotrexate in an affinity system.
    Hawkins GA; McCabe RP; Kim CH; Subramanian R; Bredehorst R; McCullers GA; Vogel CW; Hanna MG; Pomato N
    Cancer Res; 1993 May; 53(10 Suppl):2368-73. PubMed ID: 8485723
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Binding properties of monoclonal antibody to the cytoplasmic domain of transferrin receptor.
    Yoshimori T; Shimonishi Y; Uchida T
    Cell Struct Funct; 1988 Aug; 13(4):311-24. PubMed ID: 3180258
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Immunogenicity and toxicity of transferrin receptor-targeted hybrid peptide as a potent anticancer agent.
    Kawamoto M; Kohno M; Horibe T; Kawakami K
    Cancer Chemother Pharmacol; 2013 Mar; 71(3):799-807. PubMed ID: 23328867
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Transferrin Receptor-Mediated Uptake at the Blood-Brain Barrier Is Not Impaired by Alzheimer's Disease Neuropathology.
    Bourassa P; Alata W; Tremblay C; Paris-Robidas S; Calon F
    Mol Pharm; 2019 Feb; 16(2):583-594. PubMed ID: 30609376
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The transferrin receptor part I: Biology and targeting with cytotoxic antibodies for the treatment of cancer.
    Daniels TR; Delgado T; Rodriguez JA; Helguera G; Penichet ML
    Clin Immunol; 2006 Nov; 121(2):144-58. PubMed ID: 16904380
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Transferrin receptor 2: continued expression in mouse liver in the face of iron overload and in hereditary hemochromatosis.
    Fleming RE; Migas MC; Holden CC; Waheed A; Britton RS; Tomatsu S; Bacon BR; Sly WS
    Proc Natl Acad Sci U S A; 2000 Feb; 97(5):2214-9. PubMed ID: 10681454
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Radiolabeled Human Monoclonal Antibody 067-213 has the Potential for Noninvasive Quantification of CD73 Expression.
    Sudo H; Tsuji AB; Sugyo A; Kurosawa G; Kurosawa Y; Alexander D; Tsuda H; Saga T; Higashi T
    Int J Mol Sci; 2020 Mar; 21(7):. PubMed ID: 32225110
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparative binding, endocytosis, and biodistribution of antibodies and antibody-coated carriers for targeted delivery of lysosomal enzymes to ICAM-1 versus transferrin receptor.
    Papademetriou J; Garnacho C; Serrano D; Bhowmick T; Schuchman EH; Muro S
    J Inherit Metab Dis; 2013 May; 36(3):467-77. PubMed ID: 22968581
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Disparity between expression of transferrin receptor ligand binding and non-ligand binding domains on human lymphocytes.
    Boldt DH; Phillips JL; Alcantara O
    J Cell Physiol; 1987 Aug; 132(2):331-6. PubMed ID: 3624319
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.